Frazier Life Sciences Management L.P. lifted its stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 0.4% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 6,495,392 shares of the company’s stock after buying an additional 25,000 shares during the quarter. Mirum Pharmaceuticals makes up about 10.3% of Frazier Life Sciences Management L.P.’s […]
Citigroup Raises Mirum Pharmaceuticals (NASDAQ:MIRM) Price Target to $38 00 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Morgan Stanley Trims Mirum Pharmaceuticals (NASDAQ:MIRM) Target Price to $53 00 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) – Equities researchers at HC Wainwright dropped their FY2023 EPS estimates for Mirum Pharmaceuticals in a research note issued on Tuesday, February 27th. HC Wainwright analyst E. Arce now forecasts that the company will earn ($2.44) per share for the year, down from their previous estimate of ($2.13). […]
Healthcare of Ontario Pension Plan Trust Fund bought a new stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 100,000 shares of the company’s stock, valued at approximately $3,160,000. Healthcare of Ontario Pension […]